217302-90-4

Upstream product

• 4548-45-2 2-chloro-5-nitropyridine 
• 7664-93-9 sulfuric acid 
• 105-53-3 diethyl malonate 
• 14150-94-8 3,5-dinitro-1-methyl-2-pyridone 
• 107-87-9 2-Pentanone 
• 60891-70-5 1,3-diethyl 2-(5-nitropyridin-2-yl)propanedioate 
• 853915-77-2 2-<1,1-bis(ethoxycarbonyl)propyl>-5-nitropyridine 
• 18995-13-6 Diethyl ethylsodiomalonate 
• 21203-68-9 2-methyl-5-nitropyridine 

Downstream Products

• 217302-91-5 5-amino-2-propylpyridine 
• 5457-27-2 trans-5-hydroxy-2-propylpiperidine 
• 217302-98-2 7-benzyloxy-3-(4-benzyloxyphenyl)-4-ethylpyrrolo[2,1,5-cd]indolizine-1,2-dicarboxylic acid 
• 217302-97-1 dimethyl 7-benzyloxy-3-(4-benzyloxyphenyl)-4-ethylpyrrolo[2,1,5-cd]indolizine-1,2-dicarboxylate 
• 217302-95-9 6-benzyloxy-2-(4-benzyloxyphenyl)-1-ethylindolizine 
• 217302-93-7 5-benzyloxy-2-n-propylpyridine 
• 20609-24-9 6-propyl-pyridin-3-ol 

Relevant academic research and scientific papers

Tailor-made synthesis of N,N,2,6-tetrasubstituted 4-nitroanilines by three-component ring transformation of dinitropyridone

The ring transformation of dinitropyridone afforded various kinds of 2,6-disubstituted-4-nitroanilines upon treatment with aliphatic ketones in the presence of ammonium acetate as a nitrogen source, wherein dinitropyridone behaved as the synthetic equival

Pyrrolo[2,1,5-cd]indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

The present invention relates to therapeutically active compounds of formula I a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.

Synthesis and estrogen receptor binding affinities of novel pyrrolo[2,1,5-cd]indolizine derivatives

A series of pyrrolo[2,1,5-cd]indolizine derivatives has been synthesized and evaluated as ligands for the estrogen receptor. Properly substituted mono- and di-hydroxy derivatives showed binding in the low nanomolar range in accordance with their structural resemblance to estrogen. (C) 2000 Elsevier Science Ltd.

Liquid Crystalline Compounds Bearing Pyridine Ring: Azoxy Compounds with Alkyl Substituents

Azoxy compounds bearing a 2,5-disubstituted pyridine ring as a principal constituent and at least one alkyl group at a molecular end were synthesized and their mesomorphic (nematic) ranges were examined.As for azoxy compounds containing an alkyl and an alkoxy group at both ends, respectively, mesomorphic ranges appeared with lower alkyl groups than those for azo compounds, their precursors.The ranges were also lower than those with both alkoxy ends.As regards an azoxy compound containing alkyl groups at both ends, no mesomorphic phenomenon appeared within the scope of this study.